Urologic Cancer: Endoscopic, Laparoscopic, and Robot-Assisted Surgery Management (2nd Edition)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 1 May 2026 | Viewed by 77
Special Issue Editor
Interests: prostate cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to invite you to contribute to this Special Issue, which is the Second Edition of “Urologic Cancer: Endoscopic, Laparoscopic, and Robot-Assisted Surgery Management”.
The recent advances in robot-assisted urologic surgery have changed the quality of life for patients with urologic malignancy, such as prostate cancer, bladder cancer, and kidney cancer, with less invasive surgery, less blood loss, and better functional preservation. Importantly, the diagnostic value may also be changed by the recent developments in radical surgery. However, the impact of developing such a surgical modality has not been fully assessed due to the paucity of data and short follow-up period. The comparison among radiologic, open, laparoscopic, and robot-assisted surgery has not been sufficiently investigated. Moreover, transurethral and endoscopic approaches to cancer lesions have also been developed in this decade. This Special Issue calls for clinical studies and reviews on any topic in “Endoscopic, Laparoscopic, and Robot-Assisted Surgery Management”.
Dr. Kouji Izumi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- urothelial cancer
- kidney cancer
- adrenal cancer
- transurethral technique
- ureteroscopy
- ureteral stent
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
